Phase II trial evaluating the association of peripheral blood immunologic response and therapeutic response to immune checkpoint inhibition in patients with newly diagnosed glioblastoma and gliosarcomaCANCER RESEARCHIF16.62024-03-040PRE
Implantable Intracranial Pressure Sensor with Continuous Bluetooth Transmission via Mobile ApplicationJOURNAL OF PERSONALIZED MEDICINEIF32023-08-281OAAI
Response to Preoperative Dexamethasone Predicts Postoperative Neurological Improvement of Focal Neurological Deficits in Patients With Brain MetastasesNEUROSURGERYIF3.92023-01-131PRE
Immune modulatory nanoparticle therapeutics for intracerebral gliomaNEURO-ONCOLOGYIF13.42016-10-0833OAAI
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotypeJCI INSIGHTIF6.12016-02-25370OAAI
An optimized therapeutic nanoparticle delivery platform of miRNA in preclinical murine models of malignancyCANCER RESEARCHIF16.62015-08-010PRE
Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia ReactionsCLINICAL CANCER RESEARCHIF10.22015-03-017OAAI
Effect of miR-142-3p on the M2 Macrophage and Therapeutic Efficacy Against Murine GlioblastomaJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTEIF7.22014-06-28102OAAI
Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapyBLOOD CANCER JOURNALIF11.62013-09-0620OAAI